Abstract
The initial clearance of Candida albicans in situ by hepatic tissue was investigated using the isolated perfused mouse liver model in combination with various monosaccharides. When 106 yeasts were infused into untreated ICR mouse livers, approximately 61±2% (X + SEM) were recovered from the liver and 13±2% in the effluent for a total recovery of 74±2%. This suggests that 26±2% of the infused yeasts were eliminated within the liver and that a total of 87±1% were trapped (% in the liver + % killed) by the liver. In contrast, when either D-mannose or alpha-methyl-D-mannoside, but not glucose, sucrose, lactose or mannitol, were added to perfusion media (1% w/v) the ability of hepatic tissue to trap C. albicans decreased, in a dose-dependent manner, with increasing concentrations of monosaccharide. Decreased trapping was due to the interaction of these monosaccharides with hepatic tissue and not directly with yeasts. The data suggest that one component of in situ hepatic clearance of C. albicans was the binding of mannose containing structures on the surface of yeasts, most probably by hepatic mannose receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahearn DG. Medically important yeasts. Annu Rev Microbiol 1978; 32:59–68.
Ashwell G, Harfard J. Carbohydrate-specific receptors of the liver. Ann Rev Biochem 1982; 51:531–54.
Baine WB, Koenig MG, Goodman JS. Clearance of Candida albicans from the bloodstream of rabbits. Infect Immun 1974; 10:1420–25.
Barnes JL, Osgood RW, Lee JC, King RD, Stein JH. Host-parasite interactions in the pathogenesis of renal candidiasis. Lab Invest 1983; 49:460–67.
Centeno A, Davis CP, Cohen MS, Warren MM. Modulation of Candida albicans attachment to human epithelial cells by bacteria and carbohydrates. Infect Immun 1983; 39:1354–60.
Diamond RD, Oppenheim F, Nakagawa Y, Krzesicki R, Nandenschild CC. Properties of a product of Candida albicans hephae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro. J Immunol 1980; 125:2797–4.
Farrel SM, Hawkins DF, Ryder TA. Scanning electron microscope study of Candida albicans invasion of cultured human cervical epithelial cells. Sabouraudia 1983; 21:251–54.
Howlett JA, Squier CA. Candida albicans ultrastructure: colonization and invasion of oral epithelium. Infect. Immun. 1980; 29:252–60.
Kimura LH, Pearsall NN. Adherence of Candida albicans to human buccal epithelial cells. Infect Immun 1978; 21:64–68.
Kimura LH, Pearsall NN. Relationship between germination of Candida albicans and increased adherence to human buccal epithelial cells. Infect Immun 1980; 28:464–68.
King RD, Lee JC, Morris AL. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect Immun 1980; 27:667–74.
Klotz SA, Drutz DJ, Harrison JL, Huppert M. Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun 1983; 42:374–84.
Lee JC, King RD. Characterization of Candida albicans adherence to human vaginal epithelial cells in vitro. Infect Immun 1983; 41:1024–30.
McCourtie J, Douglas LJ. Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect Immun 1981; 32:1234–41.
Maisch PA, Calderone RA. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun 1980; 27:650–56.
Maisch PA, Calderone RA. Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect Immun 1981; 32:92–97.
Moon RJ, Vrable RA, Broka JA. In situ separation of bacterial trapping and killing functions of the perfused liver. Infect Immun 1975; 12:411–18.
Myerowitz RL, Pazin GJ, Allen CM. Disseminated candidiasis: changes in incidence and underlying diseases, and pathology. Am J Clin Pathol 1977; 68:29–38.
Samaranayake LP, McCourtie J, MacFarlane TW. Factors affecting the in vitro adherence of Candida albicans to acrylic surfaces. Arch Oral Biol 1980; 25:611–15.
Samaranayake LP, MacFarlane TW. The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro. Arch Oral Biol 1981; 26:815–20.
Sandin RL, Rogers AL, Patterson RJ, Beneke ES. Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro. Infect Immun 1982; 35:79–83.
Sawyer RT, Moon RJ, Beneke ES. Hepatic clearance of Candida albicans in rats. Infect Immun 1976; 14:1248–1355.
Sawyer RT, Moon RJ, Beneke ES. Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers. Infect Immun 1981; 32:945–50.
Schwocho LR, Moon RJ. Clearance and killing of Candida albicans in the perfused mouse liver. Mycopathologia 1981; 76:175–83.
Segal E, Lehrer N, Ofek I. Adherence of Candida albicans to human vaginal epithelial cells; inhibition of amino sugars. Exp Cell Biol 1982; 50:13–17.
Sobel JD, Myers PG, Kay D, Levison ME. Adherence of Candida albicans to human vaginal and buccal epithelial cells. Infect Dis 1981; 143:76–82.
Trnovec T, Sikl D, Zemanek M, Faberova V, Bezek S, Gajdosik A, Koprala V. The distribution in mice of intravenously administered labeled Candida albicans. Sabouraudia 1978; 16:299–306.
Tuttle JP, Bannister ER, Derrick FC. Interference of human spermatozoal motility and spermatozoal agglutination by Candida albicans. J Urol 1977; 118:797–99.
Wain WH, Price MF, Cawson RA. Factors affecting plaque formation by Candida albicans infecting the chick chorioallantoic membrane. Sabouraudia 1976; 14:149–54.
Wilcoxon F, Wilcox RA. Some rapid approximate statistical procedures. New York: American Cyanamide Co, 1949.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawyer, R.T. The effect of monosaccharides on in situ hepatic trapping of Candida albicans . Mycopathologia 104, 81–85 (1988). https://doi.org/10.1007/BF00436931
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00436931